Cargando…
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
Cancer immunotherapy has received extensive attention due to its ability to activate the innate or adaptive immune systems of patients to combat tumors. Despite a few clinical successes, further endeavors are still needed to tackle unresolved issues, including limited response rates, development of...
Autores principales: | Sun, Bo, Hyun, Hyesun, Li, Lian-tao, Wang, Andrew Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470849/ https://www.ncbi.nlm.nih.gov/pubmed/32424240 http://dx.doi.org/10.1038/s41401-020-0424-4 |
Ejemplares similares
-
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
por: Xu, Yanyan, et al.
Publicado: (2022) -
Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021) -
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2023) -
Harnessing RNAi nanomedicine for precision therapy
por: Peer, Dan
Publicado: (2014) -
Harnessing Protein Corona for Biomimetic Nanomedicine Design
por: Chen, Zhidong, et al.
Publicado: (2022)